These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31179715)

  • 21. Development and application of a UHPLC-MS/MS method for the simultaneous determination of 17 steroidal hormones in equine serum.
    Genangeli M; Caprioli G; Cortese M; Laus F; Matteucci M; Petrelli R; Ricciutelli M; Sagratini G; Sartori S; Vittori S
    J Mass Spectrom; 2017 Jan; 52(1):22-29. PubMed ID: 27790795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
    Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
    Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians.
    Okano M; Shiomura S
    Drug Test Anal; 2024 Jun; 16(6):595-603. PubMed ID: 37848395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new multimodal paradigm for biomarkers longitudinal monitoring: a clinical application to women steroid profiles in urine and blood.
    de Figueiredo M; Saugy J; Saugy M; Faiss R; Salamin O; Nicoli R; Kuuranne T; Rudaz S; Botrè F; Boccard J
    Anal Chim Acta; 2023 Aug; 1267():341389. PubMed ID: 37257979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of GnRH and its synthetic analogues' abuse in doping control: Small bioactive peptide UPLC-MS/MS method extension by addition of in vitro and in vivo metabolism data; evaluation of LH and steroid profile parameter fluctuations as suitable biomarkers.
    Zvereva I; Dudko G; Dikunets M
    Drug Test Anal; 2018 Apr; 10(4):711-722. PubMed ID: 28777889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
    Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
    Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of testosterone doping in female athletes.
    Handelsman DJ; Bermon S
    Drug Test Anal; 2019 Oct; 11(10):1566-1571. PubMed ID: 31454165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of dihydrotestosterone gel, oral dehydroepiandrosterone, and testosterone gel misuse through the quantification of testosterone metabolites released after alkaline treatment.
    Fabregat A; Pozo OJ; Van Renterghem P; Van Eenoo P; Marcos J; Segura J; Ventura R
    Drug Test Anal; 2011; 3(11-12):828-35. PubMed ID: 21998068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term stability study and evaluation of intact steroid conjugate ratios after the administration of endogenous steroids.
    De Wilde L; Van Renterghem P; Van Eenoo P
    Drug Test Anal; 2022 May; 14(5):851-863. PubMed ID: 33982451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of steroid hormones in plasma using a surrogate calibrant approach and UHPLC-ESI-QTOF-MS/MS with SWATH-acquisition combined with untargeted profiling.
    Drotleff B; Hallschmid M; Lämmerhofer M
    Anal Chim Acta; 2018 Aug; 1022():70-80. PubMed ID: 29729740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of an UHPLC-MS/MS method for extended serum steroid profiling in female populations.
    Salamin O; Ponzetto F; Cauderay M; Boccard J; Rudaz S; Saugy M; Kuuranne T; Nicoli R
    Bioanalysis; 2020 Jun; 12(11):753-768. PubMed ID: 32479744
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part II: Intramuscular administration.
    Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
    Drug Test Anal; 2018 May; 10(5):849-859. PubMed ID: 29166551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
    Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
    Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigations into the feasibility of routine ultra high performance liquid chromatography-tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds.
    Gray BP; Viljanto M; Bright J; Pearce C; Maynard S
    Anal Chim Acta; 2013 Jul; 787():163-72. PubMed ID: 23830435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary steroid profile in females - the impact of menstrual cycle and emergency contraceptives.
    Mullen JE; Thörngren JO; Schulze JJ; Ericsson M; Gårevik N; Lehtihet M; Ekström L
    Drug Test Anal; 2017 Jul; 9(7):1034-1042. PubMed ID: 27758048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
    Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
    J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring dehydroepiandrosterone (DHEA) in the urine of Thoroughbred geldings for doping control purposes.
    Viljanto M; Hincks P; Hillyer L; Cawley A; Suann C; Noble G; Walker CJ; Parkin MC; Kicman AT; Scarth J
    Drug Test Anal; 2018 Oct; 10(10):1518-1527. PubMed ID: 29797687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.
    Piper T; Schänzer W; Thevis M
    Drug Test Anal; 2016 Nov; 8(11-12):1163-1173. PubMed ID: 27649524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing the steroid profile in doping control analysis.
    Mareck U; Geyer H; Opfermann G; Thevis M; Schänzer W
    J Mass Spectrom; 2008 Jul; 43(7):877-91. PubMed ID: 18570179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: suitability as a potential screening parameter in doping control.
    Thieme D; Rautenberg C; Grosse J; Schoenfelder M
    Drug Test Anal; 2013; 5(11-12):819-25. PubMed ID: 24167110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.